Diversify Wealth Management LLC increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 30.5% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,997 shares of the medical equipment provider’s stock after acquiring an additional 934 shares during the quarter. Diversify Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,049,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Pinnacle Associates Ltd. raised its position in shares of Intuitive Surgical by 2.1% during the 3rd quarter. Pinnacle Associates Ltd. now owns 2,552 shares of the medical equipment provider’s stock valued at $1,254,000 after purchasing an additional 53 shares during the period. First Trust Direct Indexing L.P. increased its stake in Intuitive Surgical by 8.6% in the 3rd quarter. First Trust Direct Indexing L.P. now owns 13,483 shares of the medical equipment provider’s stock worth $6,624,000 after buying an additional 1,066 shares in the last quarter. Evermay Wealth Management LLC raised its holdings in Intuitive Surgical by 32.6% during the third quarter. Evermay Wealth Management LLC now owns 427 shares of the medical equipment provider’s stock valued at $210,000 after acquiring an additional 105 shares during the period. Creekmur Asset Management LLC lifted its position in shares of Intuitive Surgical by 288.7% in the third quarter. Creekmur Asset Management LLC now owns 1,854 shares of the medical equipment provider’s stock valued at $911,000 after acquiring an additional 1,377 shares in the last quarter. Finally, Adell Harriman & Carpenter Inc. boosted its stake in shares of Intuitive Surgical by 13.3% in the third quarter. Adell Harriman & Carpenter Inc. now owns 680 shares of the medical equipment provider’s stock worth $334,000 after acquiring an additional 80 shares during the period. Institutional investors own 83.64% of the company’s stock.
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the sale, the senior vice president now directly owns 3,001 shares of the company’s stock, valued at $1,461,006.84. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 50,095 shares of company stock worth $24,552,712 in the last quarter. 0.80% of the stock is owned by company insiders.
Intuitive Surgical Price Performance
Analyst Ratings Changes
Several analysts recently issued reports on ISRG shares. BTIG Research set a $535.00 target price on Intuitive Surgical in a research note on Friday, October 18th. Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research report on Thursday, October 17th. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Barclays boosted their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research note on Thursday, July 18th. Finally, Truist Financial lifted their target price on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a report on Monday, October 14th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $513.74.
Read Our Latest Stock Report on Intuitive Surgical
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
- Five stocks we like better than Intuitive Surgical
- Do ETFs Pay Dividends? What You Need to Know
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- What Are Some of the Best Large-Cap Stocks to Buy?
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- What is a Stock Market Index and How Do You Use Them?
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.